FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-127878.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-127878v1
23/11/3743    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cormet-Boyaka, E.
Right arrow Articles by Sorscher, E. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cormet-Boyaka, E.
Right arrow Articles by Sorscher, E. J.
(The FASEB Journal. 2009;23:3743-3751.)
© 2009 FASEB

A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice

Estelle Cormet-Boyaka*,1, Jeong S. Hong{ddagger}, Bakhram K. Berdiev{ddagger}, James A. Fortenberry§, Jessica Rennolds*, J. P. Clancy||, Dale J. Benos#, Prosper N. Boyaka{dagger} and Eric J. Sorscher§

* Division of Pulmonary, Critical Care and Sleep Medicine and

{dagger} Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA; and

{ddagger} Department of Cell Biology,

§ Department of Medicine,

|| Department of Pediatrics, and

# Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama, USA

1 Correspondence: Division of Pulmonary Critical Care and Sleep Medicine, The Ohio State University, Columbus, OH 43201, USA. E-mail: estelle.boyaka{at}osumc.edu

Cystic fibrosis (CF) is most frequently associated with deletion of phenylalanine at position 508 ({Delta}F508) in the CF transmembrane conductance regulator (CFTR) protein. The {Delta}F508-CFTR mutant protein exhibits a folding defect that affects its processing and impairs chloride-channel function. This study aimed to determine whether CFTR fragments approximately half the size of wild-type CFTR and complementary to the portion of CFTR bearing the mutation can specifically rescue the processing of endogenous {Delta}F508-CFTR in vivo. cDNA encoding CFTR fragments were delivered to human airway epithelial cells and mice harboring endogenous {Delta}F508-CFTR. Delivery of small CFTR fragments, which do not act as chloride channels by themselves, rescue {Delta}F508-CFTR. Therefore, we can speculate that the presence of the CFTR fragment, which does not harbor a mutation, might facilitate intermolecular interactions. The rescue of CFTR was evident by the restoration of chloride transport in human CFBE41o- bronchial epithelial cells expressing {Delta}F508-CFTR in vitro. More important, nasal administration of an adenovirus expressing a complementary CFTR fragment restored some degree of CFTR activity in the nasal airways of {Delta}F508 homozygous mice in vivo. These findings identify complementary protein fragments as a viable in vivo approach for correcting disease-causing misfolding of plasma membrane proteins.—Cormet-Boyaka, E., Hong, J. S., Berdiev, B. K., Fortenberry, J. A., Rennolds, J., Clancy, J. P., Benos, D. J., Boyaka, P. N., Sorscher, E. J. A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice.


Key Words: cystic fibrosis • in vivo rescue • processing • transcomplementation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.